Joel Greenblatt’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $489K | Sell |
14,952
-34,182
| -70% | -$1.23M | ﹤0.01% | 1519 |
|
|
2026
Q1 | $1.74M | Sell |
49,134
-1,214
| -2% | -$49.4K | 0.01% | 1155 |
|
|
2025
Q4 | $2.04M | Sell |
50,348
-312
| -0.6% | -$13.6K | 0.01% | 1029 |
|
|
2025
Q3 | $2.38M | Buy |
50,660
+6,164
| +14% | +$320K | 0.01% | 949 |
|
|
2025
Q2 | $2.32M | Buy |
+44,496
| New | +$2.44M | 0.01% | 881 |
|
|
2025
Q1 | – | Sell |
-4,570
| Closed | -$313K | – | 1567 |
|
|
2024
Q4 | $313K | Buy |
+4,570
| New | +$318K | ﹤0.01% | 1251 |
|
|
2024
Q3 | – | Sell |
-15,158
| Closed | -$1.05M | – | 1426 |
|
|
2024
Q2 | $1.05M | Sell |
15,158
-20,416
| -57% | -$1.49M | 0.01% | 878 |
|
|
2024
Q1 | $2.85M | Buy |
35,574
+1,555
| +5% | +$139K | 0.04% | 535 |
|
|
2023
Q4 | $3.73M | Buy |
34,019
+10,558
| +45% | +$1.09M | 0.07% | 391 |
|
|
2023
Q3 | $2.37M | Buy |
23,461
+15,497
| +195% | +$1.78M | 0.05% | 504 |
|
|
2023
Q2 | $1.08M | Buy |
7,964
+2,469
| +45% | +$301K | 0.02% | 750 |
|
|
2023
Q1 | $571K | Sell |
5,495
-244
| -4% | -$23.6K | 0.01% | 913 |
|
|
2022
Q4 | $509K | Buy |
5,739
+2,637
| +85% | +$219K | 0.01% | 884 |
|
|
2022
Q3 | $249K | Hold |
3,102
| – | – | 0.01% | 1026 |
|
|
2022
Q2 | $297K | Sell |
3,102
-92
| -3% | -$11K | 0.01% | 942 |
|
|
2022
Q1 | $474K | Sell |
3,194
-5
| -0.2% | -$698 | 0.01% | 824 |
|
|
2021
Q4 | $453K | Sell |
3,199
-6,483
| -67% | -$918K | 0.01% | 805 |
|
|
2021
Q3 | $1.27M | Buy |
9,682
+5,300
| +121% | +$693K | 0.05% | 418 |
|
|
2021
Q2 | $602K | Sell |
4,382
-1,939
| -31% | -$265K | 0.03% | 636 |
|
|
2021
Q1 | $825K | Sell |
6,321
-6,516
| -51% | -$784K | 0.04% | 539 |
|
|
2020
Q4 | $1.44M | Sell |
12,837
-2,091
| -14% | -$198K | 0.05% | 434 |
|
|
2020
Q3 | $1.17M | Sell |
14,928
-21,251
| -59% | -$1.73M | 0.04% | 495 |
|
|
2020
Q2 | $2.6M | Sell |
36,179
-11,452
| -24% | -$797K | 0.08% | 324 |
|
|
2020
Q1 | $2.73M | Buy |
47,631
+16,944
| +55% | +$1.56M | 0.08% | 343 |
|
|
2019
Q4 | $3.43M | Buy |
+30,687
| New | +$3.27M | 0.06% | 343 |
|
|
2019
Q2 | – | Sell |
-11,460
| Closed | -$953K | – | 1151 |
|
|
2019
Q1 | $953K | Sell |
11,460
-7,356
| -39% | -$534K | 0.01% | 670 |
|
|
2018
Q4 | $1.21M | Sell |
18,816
-85,515
| -82% | -$5.85M | 0.02% | 593 |
|
|
2018
Q3 | $8.27M | Buy |
104,331
+33,022
| +46% | +$2.55M | 0.11% | 257 |
|
|
2018
Q2 | $5.22M | Buy |
71,309
+39,767
| +126% | +$2.7M | 0.08% | 333 |
|
|
2018
Q1 | $2M | Sell |
31,542
-16,743
| -35% | -$1,000K | 0.03% | 504 |
|
|
2017
Q4 | $2.46M | Sell |
48,285
-29,157
| -38% | -$1.52M | 0.04% | 467 |
|
|
2017
Q3 | $4.06M | Buy |
77,442
+5,475
| +8% | +$275K | 0.06% | 405 |
|
|
2017
Q2 | $3.67M | Buy |
71,967
+31,283
| +77% | +$1.55M | 0.05% | 422 |
|
|
2017
Q1 | $1.81M | Buy |
40,684
+29,078
| +251% | +$1.25M | 0.02% | 565 |
|
|
2016
Q4 | $513K | Buy |
+11,606
| New | +$493K | 0.01% | 727 |
|
|
2014
Q3 | – | Sell |
-168,447
| Closed | -$7.44M | – | 997 |
|
|
2014
Q2 | $7.44M | Buy |
168,447
+154,980
| +1,151% | +$7.03M | 0.09% | 312 |
|
|
2014
Q1 | $585K | Buy |
+13,467
| New | +$600K | 0.01% | 761 |
|
|
2013
Q4 | – | Sell |
-19,019
| Closed | -$646K | – | 973 |
|
|
2013
Q3 | $646K | Sell |
19,019
-29,759
| -61% | -$971K | 0.02% | 650 |
|
|
2013
Q2 | $1.52M | Buy |
+48,778
| New | +$1.58M | 0.07% | 434 |
|
Other funds holding CNMD
ICM
Joel Greenblatt's CNMD Position: Q2 2026 in Review
Joel Greenblatt reduced its CONMED (CNMD) stake by 70% in Q2 2026, selling an estimated $1.23M and leaving 14,952 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.
Joel Greenblatt first reported a position in CNMD in Q2 2013 and has held it in 39 quarters since. The position peaked at $8.27M in Q3 2018. 245 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Joel Greenblatt held 14,952 shares of CONMED worth $489K as of Q2 2026.
- Joel Greenblatt sold 34,182 CONMED shares in Q2 2026, an estimated $1.23M.
- CONMED made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1519 holding.
- Joel Greenblatt first reported a position in CONMED in Q2 2013 and has held it in 39 quarters since.
- Joel Greenblatt's CONMED position peaked at $8.27M in Q3 2018.
- 245 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.